-
Washington University School of Medicine’s $616 million research facility will bring together experts in a wide variety of neurological conditions who are working toward new treatments and technologies.
-
A team of researchers led by St. Louis University professor Jenna Gorlewicz will put a $5 million grant from the National Science Foundation to work building software that will make visual materials more legible for people with visual impairments.
-
Missouri University of Science and Technology professor Mark Towler has patented a glass powder that helps wounds stop bleeding. He's now investigating whether it also can prevent infections.
-
The United States Army has granted $1.2 million to a University of Missouri researcher to study combat wound infections. The research will focus on non-intravenous, topical and localized antibiotic treatments.
-
The patented device can analyze various chemicals in people’s breath, compare them to a database, and be an initial screening for ailments including diabetes and kidney disease.
-
The research done with Yale University shows the maximum amount of light energy that can be focused at a particular point through layers of other materials like human tissue.
-
Mast cell activation syndrome provides important clues for the treatment of long COVID-19, says Dr. Leonard Weinstock of Missouri Baptist Medical Center.
-
The IpsiHand Upper Extremity Rehabilitation System recently received market authorization from the Food and Drug Administration. The device has stroke patients utilize a robotic exoskeleton on their hand and wrist, allowing them to open and close their hand using their minds.
-
The study's findings build on prior evidence that in-person learning is safe and does not contribute to COVID-19 outbreaks when schools implement safety measures.
-
Created using a common livestock virus, the lab-engineered hybrid virus infects human cells and interacts with antibodies like the coronavirus but is safer to work with in the lab. Researchers at Washington University are now testing the new virus as a possible coronavirus vaccine candidate.